ZIVO Bioscience (NASDAQ:ZIVO) Stock Passes Below 50-Day Moving Average – What’s Next?

ZIVO Bioscience, Inc. (NASDAQ:ZIVO) shares passed below its 50-day moving average during trading on Thursday . The stock has a 50-day moving average of $9.39 and traded as low as $8.25. ZIVO Bioscience shares last traded at $8.2507, with a volume of 3,975 shares traded.

ZIVO Bioscience Trading Up 0.0%

The company has a market cap of $33.02 million, a PE ratio of -1.69 and a beta of 0.23. The firm has a 50 day moving average of $9.39 and a two-hundred day moving average of $10.75.

ZIVO Bioscience Company Profile

ZIVO Bioscience is a clinical-stage biotechnology company focused on developing precision live biotherapeutics to prevent and treat gastrointestinal infections in both animal and human health markets. The company applies synthetic biology, microbiology and fermentation technologies to engineer proprietary bacterial strains that produce targeted lactic acid and antimicrobial compounds. Its pipeline includes ZB-01, an orally administered therapy for recurrent Clostridioides difficile infections in humans, and ZB-02, a feed-additive candidate aimed at reducing Salmonella colonization in poultry.

Founded in 2016 and headquartered in Carlsbad, California, ZIVO Bioscience leverages exclusive licensing agreements with academic institutions to advance its lead programs through preclinical and early clinical development.